IL1RN and atherosclerosis: Interleukin-1 receptor antagonist (IL1RN) is a natural inhibitor of IL-1, and it has been reported that IL-1, primarily expressed in the endothelium of atherosclerotic plaques, is partly regulated by IL1RN and may be associated with the inflammatory mechanism of atherosclerosis formation [23].